Skip to content

Home
About Us
Office
E-Library
Research Support
Blog
Donation
Contact Us

Home
About Us
Office
E-Library
Research Support
Blog
Donation
Contact Us

Author name: admin

New Releases from NCBI BookshelfUnderstanding How Patients’ Response to Treatment Varies Using Predicted Risk [Internet].Understanding How Patients’ Response to Treatment Varies Using Predicted Risk [Internet].

Leave a Comment / Uncategorized / admin

Pioglitazone therapy has been shown to prevent recurrent stroke in patients with insulin resistance and previous stroke but carries an […]

New Releases from NCBI BookshelfHaving Patients and Providers Identify Meaningful Changes in Rheumatoid Arthritis Symptoms [Internet].Having Patients and Providers Identify Meaningful Changes in Rheumatoid Arthritis Symptoms [Internet].

Leave a Comment / Uncategorized / admin

The Patient-Reported Outcomes Measurement Information System (PROMIS) has not been widely used in clinical practice settings. When we submitted our

New Releases from NCBI BookshelfIsatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma.Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfIsatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma.Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfPembrolizumab for untreated metastatic or unresectable recurrent head and neck squamous cell carcinoma.Pembrolizumab for untreated metastatic or unresectable recurrent head and neck squamous cell carcinoma.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfCaplacizumab with plasma exchange and immunosuppression for treating acute acquired thrombotic thrombocytopenic purpura.Caplacizumab with plasma exchange and immunosuppression for treating acute acquired thrombotic thrombocytopenic purpura.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfCaplacizumab with plasma exchange and immunosuppression for treating acute acquired thrombotic thrombocytopenic purpura.Caplacizumab with plasma exchange and immunosuppression for treating acute acquired thrombotic thrombocytopenic purpura.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfAtezolizumab with bevacizumab for treating advanced or unresectable hepatocellular carcinoma.Atezolizumab with bevacizumab for treating advanced or unresectable hepatocellular carcinoma.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfLiraglutide for managing overweight and obesity.Liraglutide for managing overweight and obesity.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfDarolutamide with androgen deprivation therapy for treating hormone-relapsed non-metastatic prostate cancer.Darolutamide with androgen deprivation therapy for treating hormone-relapsed non-metastatic prostate cancer.

Leave a Comment / Uncategorized / admin

Post Content

← Previous 1 … 65 66 67 … 164 Next →

Useful Links

NEWREDMARS SKILL AND RESEARCH FOUNDATION

Registration No: 771800548 Contact Number : +91-8249516996

Publication
Skill Development
Blog Writing

Research
Awareness Camp
Digital Research

Ngo Darpan
Service
Donation

©2021-2024. Newredmars Skill and Research Foundation. All Rights Reserved.

Term and Condition
Privacy Policy
Disclaimer

Scroll to Top